Free Trial

Genpact Limited (NYSE:G) Receives Average Recommendation of "Hold" from Brokerages

Genpact logo with Business Services background
Remove Ads

Genpact Limited (NYSE:G - Get Free Report) has received a consensus recommendation of "Hold" from the nine research firms that are covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $48.44.

Several analysts recently issued reports on G shares. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and boosted their target price for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Mizuho upped their price objective on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and raised their target price for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Needham & Company LLC boosted their price target on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a report on Friday, February 7th.

View Our Latest Stock Report on Genpact

Genpact Stock Performance

Shares of G stock traded up $0.47 on Friday, reaching $50.40. The stock had a trading volume of 108,962 shares, compared to its average volume of 1,477,457. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. Genpact has a 1 year low of $30.23 and a 1 year high of $56.76. The stock has a market cap of $8.85 billion, a P/E ratio of 17.75, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. The company has a 50 day simple moving average of $50.38 and a 200 day simple moving average of $44.78.

Remove Ads

Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Equities research analysts expect that Genpact will post 3.21 EPS for the current year.

Genpact Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, March 11th. This is a boost from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.35%. Genpact's dividend payout ratio (DPR) is currently 23.94%.

Insider Transactions at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Piyush Mehta sold 12,000 shares of the business's stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company's stock.

Hedge Funds Weigh In On Genpact

A number of large investors have recently bought and sold shares of G. Coppell Advisory Solutions LLC grew its stake in Genpact by 529.5% in the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after purchasing an additional 503 shares in the last quarter. SRH Advisors LLC acquired a new stake in Genpact in the fourth quarter worth about $26,000. Atlas Capital Advisors Inc. grew its stake in shares of Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after acquiring an additional 216 shares during the last quarter. GeoWealth Management LLC increased its holdings in shares of Genpact by 199.0% during the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after acquiring an additional 583 shares in the last quarter. Finally, Manchester Capital Management LLC purchased a new position in shares of Genpact in the 4th quarter valued at approximately $38,000. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Company Profile

(Get Free Report

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Recommended Stories

Analyst Recommendations for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Why Palantir’s Future Just Got a Massive Boost
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Stock Market on Sale – Buy Now Before the Next Big Surge

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads